Using Wellinks to Reduce COPD Hospital Readmissions
POWER: Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
This study tests if using the Wellinks app can help people with COPD avoid going back to the hospital after they’ve been treated for a flare-up.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Convexity Scientific Inc Industry-sponsored |
| Locations | 1 site (Hartford, Connecticut) |
| Trial ID | NCT05330507 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effectiveness of Wellinks, a virtual management solution for chronic obstructive pulmonary disease (COPD), in reducing hospital readmissions for patients recently discharged after an acute exacerbation. Participants will use a mobile app that integrates health coaching, Bluetooth-connected devices, and virtual pulmonary rehabilitation to manage their condition. The study will collect clinical outcomes and patient feedback to assess engagement and satisfaction with the Wellinks program.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a diagnosis of COPD who have recently been hospitalized due to an exacerbation.
Not a fit: Patients with acute coronary syndrome or those unable to participate in virtual pulmonary rehabilitation may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly lower the rate of hospital readmissions for COPD patients, improving their overall health outcomes.
How similar studies have performed: Other studies have shown promise in using virtual care solutions for chronic disease management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult (≥18 years of age with no upper age limit) 2. Any sex, race and ethnicity 3. COPD diagnosis 4. Current hospital admission or observation status resulting from exacerbation of COPD or generally including respiratory signs/symptoms indicative of difficulty breathing (e.g., need for oxygen or nebulized therapy, increased use of rescue medication) 4. Telephone (landline or mobile) and internet access 5. Access to a smartphone: iPhone 6S or later model, running iOS 14.0 or later; Android 6 or later model 6. Proficient in English language due to the availability of all study materials in the English language only 7. Living/staying in the United States throughout the study duration 8. Eligible to participate in asynchronous virtual pulmonary rehabilitation in the opinion of the investigator (e.g., patients determined to be ineligible to participate may include those with acute coronary syndrome for whom an exercise regimen is not advisable at present time) 9. Willing and able to comply with study requirements 10. Able to provide written informed consent Exclusion Criteria: 1. Diagnosis of acute decompensated heart failure 2. Currently pregnant or planning to become pregnant during the study period 3. Life expectancy \<17 weeks 4. Current participation in other interventional clinical trials 5. Current participation in a pulmonary rehabilitation program 7. Enrollment in an existing Wellinks program 8. Unable or unwilling to cooperate with remote assessments and engagement with Coaches 9. Unable to comply with the study procedures in the opinion of the investigator (e.g., unlikely to be compliant, unlikely to comprehend instructions or education provided)
Where this trial is running
Hartford, Connecticut
- Hartford Hospital — Hartford, Connecticut, United States (Recruiting)
Study contacts
- Principal investigator: Syed Hadi, MD — Hartford HealthCare
- Study coordinator: Syed Hadi, MD
- Email: syed.hadi@hhchealth.org
- Phone: 860-972-0546
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.